Propel Bio Management »

Coherus Biosciences shares owned by Propel Bio Management

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 1.4M 1.70

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Coherus Biosciences

BlackRock
Vanguard Group
Vanguard Capital Management
Samsara BioCapital
Geode Capital Management
Kohlberg Kravis Roberts & Co
Two Sigma Investments
Alyeska Investment Group
State Street Corporation
CM Management
CAM Group Holding A/S
Tang Capital Management
Hudson Bay Capital Management
PanAgora Asset Management
Propel Bio Management

View all funds holding Coherus Biosciences